NCT03773237View on ClinicalTrials.gov

Intralipid Versus SMOFlipid in HPN Patients

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

December 31, 2018

Primary Completion Date

December 1, 2023

Study Completion Date

October 1, 2024

Conditions
Short Bowel SyndromeIntestinal FistulaCrohn DiseaseIntestinal Obstruction
Interventions
DIETARY_SUPPLEMENT

SMOFLipid

SMOFLipid will be given to HPN patients to assess the benefits or adverse effects compared to Intralipid.

DIETARY_SUPPLEMENT

Intralipid

Intralipid will be given to HPN patients to assess the benefits or adverse effects compared to SMOFlipid

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER